Drug Development / Biotech

Evolva SA is a Swiss-headquartered (Allschwil/Basel), international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform.

immatics

Drugs research and development in oncology.

Addex Pharmaceuticals (IPO in 2007)

Development of novel therapeutic compounds for the treatment of central nervous system (CNS) disorders.

Actelion (IPO in 2000)

Biopharmaceutical company based in Basel (CH) dedicated to the research and development of drug therapies. Key products are:

Tracleer : oral medication for the treatment of pulmonary arterial hypertension

Zavesca : first and only oral medication indicated for the treatment of mild to moderate type I Gaucher disease

Axovan (Acquired by Actelion in 2003)

Biotech development company focusing on the development of novel GPCRs.

Cytos (IPO in 2002)

Biotech development company.